Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Proietti

Showing results (41-50 of 280) with videos related to

Pageof 28
Sort By:
International Journal of Cardiology|December 19, 2017
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trialsMarco Proietti, Gregory Y H Lip
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 1, 2025
The role of sarcopenia in determining the risk of adverse events in atrial fibrillation: advancing the need for a geriatric approachMarco Proietti, Anna Ronca, Giuseppe Boriani
JAMA Network Open|November 9, 2023
Anticoagulation in Patients With Atrial Fibrillation Who Are Frail-Toward Better CareBernadette Corica, Giulio Francesco Romiti, Marco Proietti
Thrombosis and Haemostasis|November 21, 2023
NOACs in Atrial Fibrillation Patients with PolypharmacyBernadette Corica, Giulio Francesco Romiti, Marco Proietti
Heart Rhythm|March 9, 2025
Biomarkers and prediction models: Envisioning the future of atrial fibrillation detection after strokeGiulio Francesco Romiti, Valeria Trapani, Marco Proietti
Future Cardiology|September 5, 2020
A comprehensive appraisal of dabigatran etexilate clinical evidence and applications: a 10-year-long storyGiulio Francesco Romiti, Bernadette Corica, Marco Proietti
Lancet (London, England)|March 16, 2020
Antithrombotic treatment strategies after PCIGiulio Francesco Romiti, Stefania Basili, Marco Proietti
European Journal of Internal Medicine|June 30, 2022
The case of diabetes mellitus and atrial fibrillation: Underlining the importance of non-cardiovascular comorbiditiesMarco Proietti, Giulio Francesco Romiti, Stefania Basili
Thrombosis and Haemostasis|November 21, 2018
Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and PrecisionMarco Proietti, Nebojsa Mujovic, Tatjana S Potpara
Journal of Cardiovascular Translational Research|December 5, 2018
Sex and Gender Differences in Ischemic Heart Disease: Endocrine Vascular Disease Approach (EVA) Study DesignValeria Raparelli, Marco Proietti, Andrea Lenzi, et al.
Pageof 28

Showing results (41-50 of 280) with videos related to

Sort By:
Pageof 28
International Journal of Cardiology|December 19, 2017
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trialsMarco Proietti, Gregory Y H Lip
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 1, 2025
The role of sarcopenia in determining the risk of adverse events in atrial fibrillation: advancing the need for a geriatric approachMarco Proietti, Anna Ronca, Giuseppe Boriani
JAMA Network Open|November 9, 2023
Anticoagulation in Patients With Atrial Fibrillation Who Are Frail-Toward Better CareBernadette Corica, Giulio Francesco Romiti, Marco Proietti
Thrombosis and Haemostasis|November 21, 2023
NOACs in Atrial Fibrillation Patients with PolypharmacyBernadette Corica, Giulio Francesco Romiti, Marco Proietti
Heart Rhythm|March 9, 2025
Biomarkers and prediction models: Envisioning the future of atrial fibrillation detection after strokeGiulio Francesco Romiti, Valeria Trapani, Marco Proietti
Future Cardiology|September 5, 2020
A comprehensive appraisal of dabigatran etexilate clinical evidence and applications: a 10-year-long storyGiulio Francesco Romiti, Bernadette Corica, Marco Proietti
Lancet (London, England)|March 16, 2020
Antithrombotic treatment strategies after PCIGiulio Francesco Romiti, Stefania Basili, Marco Proietti
European Journal of Internal Medicine|June 30, 2022
The case of diabetes mellitus and atrial fibrillation: Underlining the importance of non-cardiovascular comorbiditiesMarco Proietti, Giulio Francesco Romiti, Stefania Basili
Thrombosis and Haemostasis|November 21, 2018
Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and PrecisionMarco Proietti, Nebojsa Mujovic, Tatjana S Potpara
Journal of Cardiovascular Translational Research|December 5, 2018
Sex and Gender Differences in Ischemic Heart Disease: Endocrine Vascular Disease Approach (EVA) Study DesignValeria Raparelli, Marco Proietti, Andrea Lenzi, et al.
Pageof 28